Skip to main content

Table 2 Effects of dexamethasone on the body weight and the weight, RNA concentration, total RNA content, and total RNA content/body weight in EDL, SOL, and LV muscles

From: Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats

 

Group

 

Parameters

Control (n = 15)

Dexamethasone (n = 16)

Dexamethasone/controla

EDL

 Weight (mg)

152 ± 4

115 ± 2***

0.76

 Weight (mg)/body weight (g)

0.53 ± 0.01

0.52 ± 0.01

0.99

 RNA concentration (µg/g tissue)

713 ± 26

604 ± 19**

0.85

 Total RNA content (µg)

105 ± 3

68 ± 4***

0.65

 Total RNA content (µg)/body weight (g)

0.37 ± 0.01

0.31 ± 0.02*

0.84

SOL

 Weight (mg)

114 ± 3

105 ± 2*

0.92

 Weight (mg)/body weight (g)

0.40 ± 0.01

0.48 ± 0.01***

1.21

 RNA concentration (µg/g tissue)

1225 ± 37

1061 ± 37**

0.87

 Total RNA content (µg)

138 ± 4

112 ± 6***

0.81

 Total RNA content (µg)/body weight (g)

0.48 ± 0.02

0.51 ± 0.02

1.06

LV

 Weight (mg)

467 ± 30

485 ± 20

1.04

 Weight (mg)/body weight (g)

1.63 ± 0.11

2.25 ± 0.13***

1.38

 RNA concentration (µg/g tissue)

830 ± 38

845 ± 27

1.02

 Total RNA content (µg)

395 ± 38

414 ± 26

1.05

 Total RNA content (µg)/body weight (g)

1.38 ± 0.1

1.92 ± 0.2*

1.39

  1. Values are given as the mean ± SEM
  2. EDL Extensor digitorum longus, SOL soleus muscle, LV left ventricle muscle
  3. P < 0.05, **P < 0.01, ***P < 0.001 (vs. control group)
  4. aDexamethasone/control, The relative ratio of the dexamethasone group to the control group